StocksMedium•29 September 2026•
1 min read
Immix Biopharma Prices $125 Million Common Stock Offering
Key Facts
1Immix Biopharma announced the pricing of 11,363,637 shares of common stock at $11.00 per share.
2The company expects gross proceeds of $125 million from the offering before expenses.
Immix Biopharma announced the pricing of an underwritten registered offering of 11,363,637 shares of its common stock at a public offering price of $11.00 per share. The company stated in a report via GlobeNewswire that it expects gross proceeds from the offering to reach $125 million before deducting underwriting discounts and expenses.
The offering follows a session where IMMX stock closed at $11.47 on September 28, 2026, as the company seeks to raise capital for its operations. The stock traded between a low of $10.7 and a high of $11.84 on September 28, 2026, prior to the final pricing announcement.